On rendering continuous glucose monitoring ready for prime time in the cardiac care unit

Coronary Artery Disease

Volumn 18, Issue 5, 2007, Pages 405-409

  Rowen, Michaelanne ^a   Schneider, David J ^a   Pratley, Richard E ^a   Sobel, Burton E ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Acute coronary syndromes; Coronary care units; Diabetes; Glucose monitoring; Stringent glycemic control

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CLINICAL ARTICLE; CORONARY CARE UNIT; DEVICE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; IN SERVICE TRAINING; INSULIN DEPENDENCE; NURSE; NURSING STAFF; PATIENT MONITORING; PRIORITY JOURNAL;

BLOOD GLUCOSE; CORONARY CARE UNITS; CORONARY DISEASE; HUMANS; INSULIN RESISTANCE; MONITORING, PHYSIOLOGIC; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS;

EID: 34547524315     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328224bb02     Document Type: Article

References (29)

1. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2006; 345:449-461.
2. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65.
3. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000.
4. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195.
5. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Asptein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109:1497-1502.
6. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 1962; 9:166-181.
7. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971; 43:67-82.
8. Prather JW, Russell RO Jr, Mantle JA, McDaniel HG, Rackley CE. Metabolic consequences of glucose-insulin-potassium infusion in treatment of acute myocardial infarction. Am J Cardiol 1976; 38:95-99.
9. Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Rackley CE. Glucose-insulin-potassium, free fatty acids and acute myocardial infarction in man. Circulation 1976; 53:I207-I209.
10. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO Jr, Rackley CE. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol 1979; 43:801-809.
11. Apstein CS. Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. Am Heart J 2000; 139:S107-S114.
12. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dicckstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.
13. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. Circulation 2005; 111:754-760.
14. Goldberg RJ, Kramer DG, Lessard D, Yarzebski J, Gore JM. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis 2007; 18:125-131.
15. Meyer JS. Diabetes and wound healing. Crit Care Nurs Clin North Am 1996; 8:195-201.
16. Shelton RJ, Velavan P, Nikitin NP, Coletta AP, Clark AL, Rigby AS, et al. Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD ApHeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study. Eur J Heart Fail 2005; 7:127-135.
17. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446.
18. Cobb LA, Killip T, Lambrew CT, MacLeod BA, Rackley CE, Selker HP, et al. Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial. JAMA 2005; 294:2597.
19. Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2005; 46:49-50.
20. Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, et al. Use of the continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004; 79:1521-1526.
21. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971; 50:2614-2626.
22. Roberts R, Henry PD, Sobel BE. An improved basis for enzymatic estimation of infarct size. Circulation 1975; 52:743-754.
23. McGill JB, Schneider SJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 1994; 43:104-109.
24. Trost S, Prately RE, Sobel BE. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes. Curr Diab Rep 2006; 6:47-54.
25. Beeson D. Nuance, complexity, and context: qualitative methods in genetic counseling research. J Genet Counsel 1997; 6:21-43.
26. Sobel SK, Cowan DB. Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000; 90:49-59.
27. Maxwell JA. Qualitative research design: an interactive approach. 2nd ed. Thousand Oaks: Sage Publications, Inc.; 2005.
28. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educator 2006; 32:9S-18S.
29. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care 2005; 28:2543-2545.